Leukoencephalopathy with thalamus and brainstem involvement and high lactate
Alternate names[edit | edit source]
Combined oxidative phosphorylation defect type 12; Combined oxidative phosphorylation deficiency 12; COXPD12; LTBL; Leukoencephalopathy-thalamus and brainstem anomalies-high lactate syndrome
Definition[edit | edit source]
Leukoencephalopathy with thalamus and brainstem involvement and high lactate (LTBL) is a rare disorder that affects the brain. It is part of a group of disorders known as leukodystrophies.
Summary[edit | edit source]
- Leukodystrophies are diseases that affect the white matter of the brain.
- The white matter contains nerve fibers (axons), surrounded by a type of sheath or covering called myelin (a fatty, white colored substance) that allows the transmission of impulses or communication among brain cells (neurons).
Cause[edit | edit source]
- LTBL is caused by changes (mutations) in the EARS2 gene.
- Mutations in this gene decrease the amount of a specific mitochondrial enzyme needed for proper mitochondrial function (mitochondria are cell structures that convert the energy from food into a form that cells can use), and therefore, LTBL is also considered a type of mitochondrial disorder.
Inheritance[edit | edit source]
It is inherited in an autosomal recessive pattern.
Forms[edit | edit source]
There are basically two forms of the disease based on severity of symptoms and age of onset: A mild disease, with onset around 6 months of age, characterized by the loss of acquired skills (psychomotor regression), muscle stiffness (spasticity), irritability and seizures. These symptoms often improve during the toddler years.
A severe disease with symptoms that start in newborns and include brain and liver problems.
- Symptoms generally do not improve with age.
- The severity of the condition varies.
- Mildly affected individuals usually develop signs and symptoms after the age of 6 months.
- Loss of mental and movement abilities (psychomotor regression), muscle stiffness (spasticity), and extreme irritability are common, and some people with mild LTBL develop seizures.
- However, after age 2, the signs and symptoms of the condition improve: affected children regain some psychomotor abilities, seizures are reduced or disappear, MRI results become more normal, and lactate levels drop.
Signs and symptoms[edit | edit source]
- The severity of the condition varies.
- Mildly affected individuals usually develop signs and symptoms after the age of 6 months.
- Loss of mental and movement abilities (psychomotor regression), muscle stiffness (spasticity), and extreme irritability are common, and some people with mild LTBL develop seizures.
- However, after age 2, the signs and symptoms of the condition improve: affected children regain some psychomotor abilities, seizures are reduced or disappear, MRI results become more normal, and lactate levels drop.
- Severely affected individuals have features that begin soon after birth.
- These infants typically have delayed development of mental and movement abilities (psychomotor delay), weak muscle tone (hypotonia), involuntary muscle tensing (dystonia), muscle spasticity, and seizures.
- Some have extremely high levels of lactate (lactic acidosis), which can cause serious breathing problems and an abnormal heartbeat.
- Liver failure occurs in some severely affected infants.
- In severe cases, the signs and symptoms do not improve and can be life-threatening.
- In some people with LTBL, the features fall between mild and severe.
Diagnosis[edit | edit source]
- LTBL is characterized by changes in specific parts of the brain including the cerebellum, thalamus and brainstem.
- These changes can be seen by brain imaging exams (MRI).
- High levels of lactate in the blood and in the cerebral spinal fluid are also seen.
Treatment[edit | edit source]
- There is still no cure for this disease.
- Treatment is typically supportive based on presenting symptoms.
NIH genetic and rare disease info[edit source]
Leukoencephalopathy with thalamus and brainstem involvement and high lactate is a rare disease.
This article is a stub. You can help WikiMD by registering to expand it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Deepika vegiraju, Prab R. Tumpati, MD